STING is epigenetically silenced in GBM neoplastic cells, although it is expressed in inflammatory and endothelial cells within the tumor microenvironment [83], while ISGs can also be induced in neoplastic cells by IFN-independent and STING-independent mechanisms [84]. The gene discussed is STING1; the disease is glioblastoma.